In another study, serum HMGB1 and sRAGE were elevated and associated with the EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI) in patients with SS, and HMGB1 levels were much higher in patients with extra-glandular involvement (80). This evidence concerns the gene HMGB1 and synovial sarcoma.